Perioperative Management and Outcomes after Endovascular Mechanical Thrombectomy in Patients with Submassive (Intermediate-Risk) Pulmonary Embolism: A Retrospective Observational Cohort Study.
Michael P MerrenMitchell R PadkinsHector R CajigasNewton B NeidertArnoley S AbcejoOmar ElmadhounPublished in: Healthcare (Basel, Switzerland) (2024)
Pulmonary embolism (PE) embodies a large healthcare burden globally and is the third leading cause of morbidity and mortality worldwide. Submassive (intermediate-risk) PE accounts for 40% of this burden. However, the optimal treatment pathway for this population remains complex and ill-defined. Catheter-directed interventions (CDIs) have shown promise in directly impacting morbidity and mortality while demonstrating a favorable success rate, safety profile, and decreased length of stay (LOS) in the intensive care unit and hospital. This retrospective review included 22 patients (50% female) with submassive PE who underwent mechanical thrombectomy (MT). A total of 45% had a contraindication to thrombolytics, the mean pulmonary embolism severity index was 127, 36% had saddle PE, the average decrease in mean pulmonary artery pressure (PAP) was 7.2 mmHg following MT, the average LOS was 6.9 days, the 30-day mortality rate was 9%, the major adverse event (MAE) rate was 9%, and the readmission rate was 13.6%. A total of 82% had successful removal of thrombus during MT with no major bleeding complications, intracranial hemorrhage events, or device-related deaths. Acknowledging the limitation of our small sample size, our data indicate that MT in the intermediate-high-risk submassive pulmonary embolism (PE) cohort resulted in a decreased hospital length of stay (LOS) and in-hospital mortality compared to standard anticoagulation therapy alone.
Keyphrases
- pulmonary embolism
- pulmonary artery
- healthcare
- inferior vena cava
- coronary artery
- end stage renal disease
- pulmonary hypertension
- risk factors
- pulmonary arterial hypertension
- atrial fibrillation
- ejection fraction
- chronic kidney disease
- newly diagnosed
- big data
- venous thromboembolism
- cardiovascular events
- adverse drug
- emergency department
- peritoneal dialysis
- stem cells
- machine learning
- type diabetes
- acute kidney injury
- artificial intelligence
- optical coherence tomography
- social media